Bank Of America Corp Coherus Bio Sciences, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 661,680 shares of CHRS stock, worth $727,848. This represents 0.0% of its overall portfolio holdings.

Number of Shares

661,680

Previous 275,095 140.53%

Holding current value

$727,848

Previous $475,000 44.84%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.99 - $1.8 $382,719 - $695,853	386,585 Added 140.53%	661,680 $688,000
Q2 2024 Aug 14, 2024	SELL	$1.58 - $2.51 $3.4 Million - $5.4 Million	-2,152,130 Reduced 88.67%	275,095 $475,000
Q1 2024 May 15, 2024	BUY	$2.02 - $3.14 $623,010 - $968,441	308,421 Added 14.56%	2,427,225 $5.8 Million
Q4 2023 Feb 14, 2024	BUY	$1.59 - $3.85 $3.1 Million - $7.51 Million	1,949,629 Added 1152.43%	2,118,804 $7.06 Million
Q2 2023 Aug 14, 2023	SELL	$3.79 - $8.3 $1.51 Million - $3.31 Million	-398,199 Reduced 70.18%	169,175 $722,000
Q1 2023 May 12, 2023	BUY	$5.89 - $10.52 $1.09 Million - $1.95 Million	184,924 Added 48.35%	567,374 $3.88 Million
Q4 2022 Feb 10, 2023	BUY	$5.69 - $10.07 $633,695 - $1.12 Million	111,370 Added 41.08%	382,450 $3.03 Million
Q3 2022 Nov 14, 2022	BUY	$7.17 - $13.87 $419,029 - $810,590	58,442 Added 27.48%	271,080 $2.61 Million
Q2 2022 Aug 12, 2022	SELL	$5.86 - $13.23 $198,976 - $449,224	-33,955 Reduced 13.77%	212,638 $1.54 Million
Q1 2022 May 16, 2022	BUY	$10.92 - $16.41 $440,949 - $662,635	40,380 Added 19.58%	246,593 $3.18 Million
Q4 2021 Feb 08, 2022	SELL	$15.81 - $18.99 $893,802 - $1.07 Million	-56,534 Reduced 21.52%	206,213 $3.29 Million
Q3 2021 Nov 15, 2021	BUY	$12.68 - $17.79 $136,436 - $191,420	10,760 Added 4.27%	262,747 $4.22 Million
Q2 2021 Sep 13, 2021	BUY	$12.95 - $15.41 $3.26 Million - $3.88 Million	251,987 New	251,987 $3.49 Million

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $85.5M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Coherus Bio Sciences, Inc. Transaction History